MANGALAM DRUGS Fact Sheet, MANGALAM DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANGALAM DRUGS Fact Sheet    (MANGD)


REVEALED: Brijesh Bhatia's Private Telegram Channel (JOIN NOW)


Here is the latest financial fact sheet of MANGALAM DRUGS. For more details, see the MANGALAM DRUGS quarterly results and MANGALAM DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

MANGALAM DRUGS Price History

Price Rs 184.8
Mkt Cap Rs m 2,925
Vol '000 21.9
P/E X 10.5
P/CF X 17.8
EPS (TTM) Rs 17.7
% ch % -2.6
No. of shares m 15.83
% ch week % -2.3
% ch 1-mth % 24.4
% ch 12-mth % 172.0
52 week H/L Rs 196.5/65.5
(As on Aug 4, 2021 12:10:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

MANGALAM DRUGS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
MANGALAM DRUGS EQUITY SHARE DATA
High Rs44225622618260 
Low Rs261231264020 
Sales per share (Unadj.) Rs199.5185.3158.6124.0158.9 
Earnings per share (Unadj.) Rs11.114.112.6-5.15.2 
Diluted earnings per shareRs10.114.112.6-5.15.2 
Cash flow per share (Unadj.) Rs14.217.216.7-0.610.4 
Dividends per share (Unadj.) Rs000.5000 
Adj. dividends per shareRs0.000.000.500.000.00 
Dividend yield (eoy) %000.300 
Book value per share (Unadj.) Rs36.954.165.660.465.7 
Adj. book value per shareRs33.554.265.660.465.7 
Shares outstanding (eoy) m14.3815.8315.8315.8315.83 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.21.01.10.90.3 
Avg P/E ratio x20.913.514.0-21.97.7 
P/CF ratio (eoy) x16.411.010.5-186.63.9 
Price / Book Value ratio x6.33.52.71.80.6 
Dividend payout %004.000 
Avg Mkt Cap Rs m3,3593,0022,7811,758635 
No. of employees `000NANANANANA 
Total wages/salary Rs m144191230258260 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
MANGALAM DRUGS INCOME DATA
Net Sales Rs m2,8692,9332,5111,9632,516 
Other income Rs m238312 
Total revenues Rs m2,8712,9362,5191,9672,528 
Gross profit Rs m37545946997237 
Depreciation Rs m4450667182 
Interest Rs m9310011886104 
Profit before tax Rs m240312293-5763 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m80899523-20 
Profit after tax Rs m160223199-8083 
Gross profit margin %13.115.718.74.99.4 
Effective tax rate %33.228.632.2-40.0-32.0 
Net profit margin %5.67.67.9-4.13.3 
MANGALAM DRUGS BALANCE SHEET DATA
Current assets Rs m9979581,2281,0501,192 
Current liabilities Rs m7297789989081,095 
Net working cap to sales %9.36.19.27.23.9 
Current ratio x1.41.21.21.21.1 
Inventory Days Days233513 
Debtors Days Days3846663358 
Net fixed assets Rs m6019371,0391,0631,115 
Share capital Rs m144158158158158 
"Free" reserves Rs m387699879798881 
Net worth Rs m5308571,0389571,039 
Long term debt Rs m1691691118642 
Total assets Rs m1,5981,8952,2682,1142,307 
Interest coverage x3.64.13.50.31.6 
Debt to equity ratio x0.30.20.10.10 
Sales to assets ratio x1.81.51.10.91.1 
Return on assets %15.917.114.00.38.1 
Return on equity %30.226.019.2-8.47.9 
Return on capital %47.640.235.82.815.4 
Exports to sales %000036.5 
Imports to sales %59.553.367.769.659.5 
Exports (fob) Rs m0000919 
Imports (cif) Rs m1,7081,5621,7001,3661,496 
Fx inflow Rs m492850588423919 
Fx outflow Rs m1,7151,5671,7061,3721,499 
Net fx Rs m-1,223-717-1,118-949-580 
MANGALAM DRUGS CASH FLOW
From Operations Rs m 218 428 246 217 305 
From Investments Rs m -109 -394 -160 -93 -69 
From Financial Activity Rs m -111 -32 -88 -114 -235 
Net Cashflow Rs m -2 1 -2 10 2 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 50.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 49.5%
Shareholders 21,827
Pledged promoter(s) holding 33.6%
 

Company Information

REGD OFF ‘3” Floor, 237 Rupam Building, P. D. Mello Road, Mumbai - 400001
E-MAIL contactus@mangalamdrugs.com WEB www.mangalamdrugs.com
TEL 91-22-22616200/ 6300/8787 FAX 91-22-2619090
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1972 BSE CODE: 532637 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ASPIRA PATHLAB & DIAGNOSTICS   ZOTA HEALTH CARE  SANJIVANI PA  BRAWN BIOTECH  ZENITH HEALTH  

Compare MANGALAM DRUGS With:   ASPIRA PATHLAB & DIAGNOSTICS   ZOTA HEALTH CARE  SANJIVANI PA  BRAWN BIOTECH  ZENITH HEALTH  




Today's Market

Sensex, Nifty Open at Record High; HDFC & ICICI Bank Top Gainers(09:30 am)

Asian share markets advanced to one-week highs, led largely by strong US corporate earnings, although the mood remained cautious as the rapidly spreading Delta variant of the coronavirus.

Views on news

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks (Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

The Road to 100 Baggers Begins Here (Profit Hunter)

Jul 22, 2021

How to be an early investor in future 100 baggers.

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks (Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MANGALAM DRUGS

  • Track your investment in MANGALAM DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MANGALAM DRUGS

MANGALAM DRUGS 8-QTR ANALYSIS

COMPARE MANGALAM DRUGS WITH

MARKET STATS